tiprankstipranks
Trending News
More News >

UBS Reduces Holdings in Renalytix PLC Below 5%

Story Highlights
UBS Reduces Holdings in Renalytix PLC Below 5%

Don’t Miss TipRanks’ Half-Year Sale

Renalytix ( (GB:RENX) ) has shared an announcement.

Renalytix PLC has announced that UBS Group AG’s trading book holdings in the company have fallen below 5%, exempting them from reporting obligations. This change in UBS’s holdings could impact Renalytix’s market dynamics and investor perceptions, as it reflects a shift in the investment strategy of a major financial institution.

More about Renalytix

Renalytix PLC operates in the healthcare industry, specializing in the development of artificial intelligence-enabled diagnostics for kidney disease. The company focuses on improving kidney health outcomes by providing advanced diagnostic solutions for early detection and risk assessment of kidney diseases.

YTD Price Performance: 13.75%

Average Trading Volume: 404

Technical Sentiment Signal: Buy

Current Market Cap: $38.63M

See more data about RENX stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1